Question for those that might know... Is it possible to have Amerex submit our 50% interim analysis to the FDA in the Philippines by way of our partner in the Philippines and Cytodyn still stay CD-12 blinded here in the USA? Kinda like liars poker? We can’t see it but they can?
Also, they have our CD-10 trial info and some if not all of our EIND. Since we showed statistical improvement in both all though one is anecdotal. Is it possible to receive the Mild to Moderate approval first in the Philippines? This change by the Philippines FDA was meant to get them into the game earlier than they rest for Covid break through therapeutics. Then soon after EUA for Severe to Critical...
Could this be something that has been in the works since October 12th since we signed a deal with a partner in the Philippines? It’s quite sneaky for Cytodyn to post this after hours and on a weekend. I am sure there are many opinions on this move and it will be weighed out over the weekend.
Also, they have our CD-10 trial info and some if not all of our EIND. Since we showed statistical improvement in both all though one is anecdotal. Is it possible to receive the Mild to Moderate approval first in the Philippines? This change by the Philippines FDA was meant to get them into the game earlier than they rest for Covid break through therapeutics. Then soon after EUA for Severe to Critical...
Could this be something that has been in the works since October 12th since we signed a deal with a partner in the Philippines? It’s quite sneaky for Cytodyn to post this after hours and on a weekend. I am sure there are many opinions on this move and it will be weighed out over the weekend.
